| Name: | Dexamethasone Acetate EP Impurity I |
| Catalogue No. | VE005877 |
| CAS No. | N/A |
| Molecular Formula | C26H33FO7 |
| Molecular Weight | 476.22 |
| Status | In-stock |
| IUPAC Name | 2-((8S,9R,10S,11S,13S,14S,16R,17R)-11-acetoxy-9-fluoro-17-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
| Appearance | Off white powder |
| Description | Dexamethasone Acetate EP Impurity I is an adulteration of Dexamethasone which is a synthetic corticosteroid holding anti-inflammatory and immunosuppressive properties that can be used as an anti-inflammatory agent. |
| References | Dongala, Thirupathi, et al. “Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment prior to Method Validation by Quality by Design Approach.” Chromatographia, vol. 83, no. 10, Aug. 2020, pp. 1269–81,https://doi.org/10.1007/s10337-020-03945-5.Das, Saibal Kumar, et al. “Improvements in Corticosteroid 21-Acetoxy-17α-Hydroxy-16α-Methyl-Pregna-1,4,9(11)-Triene-3,20-Dione Synthesis and Its Use as C |
![(16α)-21-[(Ethoxycarbonyl)oxy]-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione](/public/site/files/site_images/thumb_16alpha-21-ethoxycarbonyl-oxy-17-hydroxy-16-methylpregna-1-4-9-11-triene-3-20-dione47031.png)